| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52086740f302f427f4df239ef8a1ccb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-78 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49 |
| filingDate |
2013-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1cfc4ce24c56295fab532ee43691f23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45549d8218908bf197371a8e2d366317
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_234ac28fdfb36da8166d5a6514acf9f6 |
| publicationDate |
2019-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2734480-T3 |
| titleOfInvention |
Composition comprising melatonin or its derivatives with coenzyme Q10 and its use against skin aging |
| abstract |
The present invention relates to a composition comprising melatonin, metabolite or derivative thereof and coenzyme Q10 and its use for the preparation of a cosmetic or pharmaceutical composition for the treatment of the skin, since this composition enhances the entry of both molecules in the mitochondria and facilitates transdermal absorption, being able to reach both melatonin and CoQ10 in all layers of the skin. |
| priorityDate |
2012-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |